Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia

Amgen

Status: Completed

Conditions: Acute Lymphoblastic Leukemia

Treatments: Other: Not applicable - observational study

Study type: Observational

Funder types: Industry

Identifiers

NCT02003612

20120310

Details and patient eligibility

About

A retrospective analysis of historical data looking at hematological remission and survival in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients.

Full description

A retrospective observational study reviewing historical survival data (hematological remission and survival) for adult patients who have either relapsed or refractory B-precursor acute lymphoblastic leukemia. Data are aggregated across multiple countries and study sites in the EU and US

Enrollment: 2,373 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• adult patients with relapsed / refractory B-precursor acute lymphoblastic leukemia
• age 15 or older at time of de novo (initial) diagnosis of acute lymphoblastic leukemia
• initial diagnosis of acute lymphoblastic leukemia in the year 1990 or later
• No CNS involvement at relapse
• No isolated extramedullary relapse
• Other inclusion criteria may apply

Trial design

2,373 participants in 1 patient group

All subjects

Description:

All subjects

Treatment:

Other: Not applicable - observational study